Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organization that would benefit ...

The results to be presented by Prof Emmett at the EAU Congress 2026 will expand on the earlier findings that the trial met its primary endpoint, demonstrating that 64 Cu-SAR-bisPSMA positron emission ...

There is a shadow disease that often lurks unnoticed, growing quietly within a man’s body which is hidden behind the mundane routine of daily life, masked by ag ...

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec. 23, ...

Coversure Insurance Brokers has launched a network-wide prostate cancer screening initiative, funding free prostate-specific ...

Health experts have stressed the importance of routine prostate cancer screening among men, particularly those aged 40 years ...

A community health initiative offering 300 free prostate‑specific antigen (PSA) screenings to the public has been launched.

A world-first Australian clinical trial has found that a new combination of therapies could slow the spread of advanced prostate cancers.The EVOLUTION ...

MELBOURNE, Australia and INDIANAPOLIS, /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') today ...

A leading doctor has answered several common questions about prostate cancer in an effort to separate facts from fiction. His ...

A prominent doctor has tackled several frequently asked questions regarding prostate cancer in a bid to distinguish fact from ...